Effects of interventional vascular embolization at different timing on prognosis and serum S100 calcium-binding protein B level of patients with aneurysmal subarachnoid hemorrhage
{"title":"Effects of interventional vascular embolization at different timing on prognosis and serum S100 calcium-binding protein B level of patients with aneurysmal subarachnoid hemorrhage","authors":"Peidong Yue, Lei Zhang, Bin Wang","doi":"10.4314/ahs.v23i3.65","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate the effects of interventional vascular embolization at different timing on the prognosis and serum S100calcium-binding protein B (S100B) level of patients with aneurysmal subarachnoid hemorrhage (aSAH).
 Methods: A total of 229 aSAH patients enrolled from January 2016 to January 2020 were divided into an early-stage group(n=66), a middle-stage group (n=95) and a late-stage group (n=68. Their baseline data, serum indices and clinical outcomes werecompared. The factors affecting their prognosis were analysed. The value of serum S100B level for predicting the prognosis wasevaluated.
 Results: The early-stage group had the highest GOS score, and the late-stage group had the lowest score (P<0.05). Older age,large diameter of aneurysm, high Hunt-Hess grade upon admission, late surgical treatment and high S100B level were risk factorsfor the poor prognosis of aSAH patients. The optimal cut-off value of S100B for predicting the prognosis was 2.785 μg/L.The area under the receiver operator characteristic curve, sensitivity, specificity, Youden index and 95% confidence interval were0.892, 84.3%, 86.3%, 0.706 and 0.844-0.940, respectively.
 Conclusion: Early vascular interventional embolization is beneficial to the alleviation of brain injury and the reduction of serumS100B level.
 Keywords: Aneurysmal subarachnoid hemorrhage; interventional vascular embolization; prognosis; S100 calcium-binding proteinB; timing.","PeriodicalId":7853,"journal":{"name":"African Health Sciences","volume":"26 1","pages":"0"},"PeriodicalIF":0.8000,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"African Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/ahs.v23i3.65","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To evaluate the effects of interventional vascular embolization at different timing on the prognosis and serum S100calcium-binding protein B (S100B) level of patients with aneurysmal subarachnoid hemorrhage (aSAH).
Methods: A total of 229 aSAH patients enrolled from January 2016 to January 2020 were divided into an early-stage group(n=66), a middle-stage group (n=95) and a late-stage group (n=68. Their baseline data, serum indices and clinical outcomes werecompared. The factors affecting their prognosis were analysed. The value of serum S100B level for predicting the prognosis wasevaluated.
Results: The early-stage group had the highest GOS score, and the late-stage group had the lowest score (P<0.05). Older age,large diameter of aneurysm, high Hunt-Hess grade upon admission, late surgical treatment and high S100B level were risk factorsfor the poor prognosis of aSAH patients. The optimal cut-off value of S100B for predicting the prognosis was 2.785 μg/L.The area under the receiver operator characteristic curve, sensitivity, specificity, Youden index and 95% confidence interval were0.892, 84.3%, 86.3%, 0.706 and 0.844-0.940, respectively.
Conclusion: Early vascular interventional embolization is beneficial to the alleviation of brain injury and the reduction of serumS100B level.
Keywords: Aneurysmal subarachnoid hemorrhage; interventional vascular embolization; prognosis; S100 calcium-binding proteinB; timing.
期刊介绍:
The African Health Sciences is an internationally refereed journal publishing original articles on research, clinical practice, public health, policy, planning, implementation and evaluation, in the health and related sciences relevant to Africa and the tropics. Its objectives are to: Advocate for and promote the growth of reading culture in sub Saharan Africa; Provide a high quality journal in which health and policy and other researchers and practitioners in the region can and world wide, can publish their work; Promote relevant health system research and publication in the region including alternative means of health care financing, the burden of and solution of health problems in marginalized urban and rural communities amongst the displaced and others affected by conflict; Promote research and the systematic collection and collation and publication of data on diseases and conditions of equity and influence; Promote development of evidence-based policies and guidelines for clinical, public health and other practitioners. African Health Sciences acknowledges support provided by the African Health Journals Partnership Project that is funded by the US National Institutes of Health (through the National Library of Medicine and the Fogarty International Center) and facilitated by the Council of Science Editors.